What is the current COVID-19 Diagnostic Testing market size?

The COVID-19 Diagnostic Testing market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the COVID-19 Diagnostic Testing market?

Key drivers include rising COVID-19 cases, advancements in testing technology, and government initiatives.

What challenges does the COVID-19 Diagnostic Testing market face?

Challenges include high development costs, regulatory hurdles, and intense competition among manufacturers.

Which regions are leading the COVID-19 Diagnostic Testing market?

North America and Europe are currently leading the market due to high adoption rates and advanced healthcare infrastructure.

Who are the top companies in the COVID-19 Diagnostic Testing market?

Top companies include Roche, Abbott, and BioMerieux, which offer a wide range of diagnostic testing solutions.

What future opportunities exist in the COVID-19 Diagnostic Testing market?

Future opportunities include the development of point-of-care testing and the integration of artificial intelligence in diagnostic systems.

How is technology impacting the COVID-19 Diagnostic Testing market?

Technology is enabling faster, more accurate testing with the use of PCR, antigen, and molecular diagnostics.

What is the current regulatory landscape for the COVID-19 Diagnostic Testing market?

The regulatory landscape is evolving with the FDA and EU regulators issuing guidelines for emergency use authorization and approval.

What is the future outlook for the COVID-19 Diagnostic Testing market?

The future outlook is positive with increasing adoption of diagnostic testing and rising investment in research and development.

COVID-19 Diagnostic Testing Market: Opportunity by 2034 | In-Depth Report

COVID-19 Diagnostic Testing by Application (Hospitals, Scientific Research), by Types (Nucleic Acid Testing, Antibody Testing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

COVID-19 Diagnostic Testing Market Size | CAGR 10.2 Forecast 2033

COVID-19 Diagnostic Testing Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

COVID-19 Diagnostic Testing Market Overview

The COVID-19 Diagnostic Testing market refers to the industry that provides diagnostic tests for the detection of COVID-19. As the world continues to grapple with the pandemic, the COVID-19 Diagnostic Testing market size is estimated to be around $13.2 billion in 2025. The growth outlook for this market is positive, with a expected market forecast to reach $24.1 billion by 2033, driven by the increasing demand for rapid and accurate diagnostic tests. The industry expansion is expected to be driven by advancements in technology, government initiatives, and the rising awareness about the importance of diagnostic testing.

Loading chart…

The growth forecast for the COVID-19 Diagnostic Testing market is expected to be driven by a CAGR of 8.5% from 2026 to 2033. The key forces shaping the industry include technology shifts towards rapid and point-of-care testing, regulations and guidelines set by government agencies, and consumer behavior driven by the increasing awareness about the importance of diagnostic testing. The largest region for the COVID-19 Diagnostic Testing market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be driven by the increasing demand for diagnostic tests, advancements in technology, and government initiatives to combat the pandemic.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cellex; Abbott; Roche; BioMedomics; BD; Henry Schein; Safecare Bio-Tech; Mayo Clinic Laboratories; Chembio Diagnostics; Mount Sinai Laboratory; Ortho Clinical Diagnostics; Zhejiang Orient Gene Biotech; Innovita Biological Technology; Guangzhou Wondfo Biotech; Guangdong Hecin-Scientific; Dynamiker Biotechnology (Tianjin); ADVAITE; Segal
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The COVID-19 Diagnostic Testing market is experiencing significant fluctuations due to various factors influencing its growth forecast. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Increasing demand for rapid and accurate diagnostic tests is driving the COVID-19 Diagnostic Testing market size, fueled by the ongoing pandemic and the need for timely patient care.

Advancements in technology, such as the development of point-of-care tests and molecular diagnostics, are expanding the market's reach and capability, thus influencing the growth forecast of the COVID-19 Diagnostic Testing market.

Restraints2 items

Stringent regulatory requirements and the need for emergency use authorizations are limiting the entry of new players into the COVID-19 Diagnostic Testing market, thereby affecting its growth forecast.

Supply chain disruptions and shortages of critical components are hindering the production and distribution of diagnostic tests, impacting the COVID-19 Diagnostic Testing market size.

Opportunities2 items

The integration of artificial intelligence and machine learning in diagnostic testing presents opportunities for improving test accuracy and efficiency, potentially expanding the COVID-19 Diagnostic Testing market.

The growing demand for at-home testing kits and self-testing solutions is creating new avenues for market growth, contributing to the overall growth forecast of the COVID-19 Diagnostic Testing market.

Challenges2 items

Ensuring the accuracy and reliability of diagnostic tests, especially in low-resource settings, remains a significant challenge for the COVID-19 Diagnostic Testing market, affecting its growth forecast.

Managing the cost of diagnostic testing and ensuring equitable access to these tests worldwide are critical challenges that the COVID-19 Diagnostic Testing market must address to achieve sustainable growth and meet the COVID-19 Diagnostic Testing market size expectations.

Market Segmentation

Loading chart…

The Application segment in the COVID-19 Diagnostic Testing market refers to the various uses of diagnostic tests, including clinical diagnosis, research, and surveillance. This segmentation is crucial as it helps in understanding the different areas where diagnostic tests are being utilized, thereby contributing to the overall COVID-19 Diagnostic Testing market size. The COVID-19 Diagnostic Testing segmentation by application provides valuable insights into the market, enabling stakeholders to make informed decisions. The application segment is further divided into subtypes, such as [object Object], [object Object], which are essential in determining the market size and growth prospects.

The Types segment in the COVID-19 Diagnostic Testing market encompasses various subtypes of diagnostic tests, including molecular tests, antigen tests, and antibody tests. Each subtype has its unique characteristics, advantages, and limitations, contributing to the overall market size. The types segment is critical in understanding the market taxonomy, as it helps in identifying the different types of tests being used, their market share, and growth prospects. The COVID-19 Diagnostic Testing market taxonomy is essential in providing a comprehensive understanding of the market, enabling stakeholders to navigate the complex landscape and make informed decisions. The types segment is a critical component of the COVID-19 Diagnostic Testing segmentation, as it helps in determining the market size, growth prospects, and trends.

COVID-19 Diagnostic Testing Segmentation Breakdown6 items

Application

Hospitals

Scientific Research

Types

Nucleic Acid Testing

Antibody Testing

Regional Insights

Loading chart…

The COVID-19 Diagnostic Testing market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of diagnostic testing, government policies supporting healthcare infrastructure development, and rising investments in research and development. Key drivers in North America include established infrastructure, high ecosystem maturity, and significant investments in COVID-19 research.

In Europe, key drivers include strong healthcare policies, growing demand for diagnostic testing, and collaborations between healthcare providers and research institutions. Asia Pacific's growth is further fueled by large demographics, increasing healthcare expenditure, and expanding distribution networks. Latin America and Middle East & Africa are expected to experience steady growth, driven by improving infrastructure, growing awareness of COVID-19 diagnostic testing, and rising investments in healthcare development.

Regional Drivers4 items

North America: established infrastructure, high ecosystem maturity, significant investments

Europe: strong healthcare policies, growing demand, collaborations between healthcare providers and research institutions

Asia Pacific: large demographics, increasing healthcare expenditure, expanding distribution networks

Latin America and Middle East & Africa: improving infrastructure, growing awareness, rising investments in healthcare development

Competitive Landscape

The COVID-19 Diagnostic Testing market is moderately consolidated, with a mix of global players and local/regional companies competing on various fronts, including pricing, distribution, product innovation, certifications, and regulatory approvals. The COVID-19 Diagnostic Testing competitive landscape is characterized by high competition, with key players employing different strategies to differentiate themselves. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local players are leveraging their regional presence and cost advantages to compete.

Companies in the market are adopting various strategies, such as M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. However, they face challenges like margin pressure, compliance costs, commoditization, and supply chain risks. To differentiate themselves, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are implementing different strategic focuses:

Cellex: regional expansion

Abbott: innovation pipeline

Roche: premium pricing

BioMedomics: OEM tie-ups

BD: vertical integration

Henry Schein: local manufacturing

Key COVID-19 Diagnostic Testing Companies18 items

Cellex

Abbott

Roche

BioMedomics

Henry Schein

Safecare Bio-Tech

Mayo Clinic Laboratories

Chembio Diagnostics

Mount Sinai Laboratory

Ortho Clinical Diagnostics

Zhejiang Orient Gene Biotech

Innovita Biological Technology

Guangzhou Wondfo Biotech

Guangdong Hecin-Scientific

Dynamiker Biotechnology (Tianjin)

ADVAITE

Segal

Market Ecosystem

The COVID-19 Diagnostic Testing ecosystem encompasses a complex network of stakeholders, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers develop diagnostic testing solutions; and downstream, where channels and end users interact. Value is created and captured at each stage, with technology providers supplying critical components, integrators developing testing kits, and end users driving demand.

Raw material/component suppliers — providing critical components

Technology providers — developing diagnostic technologies

OEMs / manufacturers — producing testing kits and equipment

System integrators / EPCs — integrating testing solutions

Distributors / channel partners — delivering testing kits to end users

Regulators/standards bodies — overseeing testing standards and approvals

End users / buyers — driving demand for diagnostic testing solutions

In the COVID-19 Diagnostic Testing ecosystem, control points are largely influenced by regulators and standards bodies, who oversee testing standards and approvals. Dependency risks arise from input constraints, such as supply chain disruptions, and standards, which can impact the development and deployment of diagnostic testing solutions. Switching costs and partnerships can also be significant, particularly for end users who may be locked into specific testing platforms or solutions. Furthermore, the ecosystem differs by region, with varying regulatory requirements, testing protocols, and healthcare infrastructure influencing the adoption and implementation of diagnostic testing solutions, highlighting the need for a nuanced value chain analysis.

Recent Industry Insights

The COVID-19 Diagnostic Testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading diagnostic companies and research institutions have accelerated the development of innovative testing solutions. Notable mergers and acquisitions have also taken place, enabling companies to expand their product portfolios and strengthen their market presence. Furthermore, several product and technology launches have improved testing accuracy and efficiency, while regulatory changes have ensured stricter quality control measures.

The shift in consumer and enterprise trends has led to increased adoption of point-of-care testing and at-home diagnostic kits. Additionally, funding rounds and expansions have enabled companies to invest in research and development, driving growth in the COVID-19 Diagnostic Testing market. These developments are expected to continue shaping the industry landscape, influencing COVID-19 Diagnostic Testing industry trends and driving innovation in the months to come.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the COVID-19 Diagnostic Testing market outlook. The market attractiveness is moderately high, driven by the ongoing need for accurate and rapid diagnostic testing. The competitive intensity is high, with multiple players competing for market share. The long-term outlook is positive, with advancements in technology and innovation expected to drive growth.

The innovation landscape is rapidly evolving, with point-of-care testing and molecular diagnostics emerging as key areas of focus. The demand-supply balance is currently skewed, with demand outpacing supply in some regions. Key risk factors include regulatory changes, supply chain disruptions, and the emergence of new variants. Overall, the COVID-19 Diagnostic Testing market outlook is favorable, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. COVID-19 Diagnostic Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global COVID-19 Diagnostic Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global COVID-19 Diagnostic Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Scientific Research

6.2. Global COVID-19 Diagnostic Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Nucleic Acid Testing

6.2.2. Antibody Testing

6.3. Global COVID-19 Diagnostic Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global COVID-19 Diagnostic Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global COVID-19 Diagnostic Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global COVID-19 Diagnostic Testing Market Competition by Key Manufacturers

8.1. Global COVID-19 Diagnostic Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global COVID-19 Diagnostic Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cellex

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Roche

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BioMedomics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BD

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Henry Schein

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Safecare Bio-Tech

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Mayo Clinic Laboratories

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Chembio Diagnostics

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Mount Sinai Laboratory

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Ortho Clinical Diagnostics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Zhejiang Orient Gene Biotech

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Innovita Biological Technology

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Guangzhou Wondfo Biotech

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Guangdong Hecin-Scientific

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Dynamiker Biotechnology (Tianjin)

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. ADVAITE

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Segal

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global COVID-19 Diagnostic Testing Market

Figure 4: Global COVID-19 Diagnostic Testing Market: Drivers

Figure 5: Global COVID-19 Diagnostic Testing Market: Challenges

Figure 6: Global COVID-19 Diagnostic Testing Market: Trends

Figure 7: Global COVID-19 Diagnostic Testing Market: Opportunity

Figure 8: Global COVID-19 Diagnostic Testing Market: Restraint

Figure 9: Global COVID-19 Diagnostic Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global COVID-19 Diagnostic Testing Market Value (USD Million) By Region

Figure 15: Global COVID-19 Diagnostic Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global COVID-19 Diagnostic Testing Market Value (USD Million) By Region

Figure 23: Global COVID-19 Diagnostic Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global COVID-19 Diagnostic Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global COVID-19 Diagnostic Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global COVID-19 Diagnostic Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global COVID-19 Diagnostic Testing Market Value (USD Million) By Region

Table 10: Global COVID-19 Diagnostic Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global COVID-19 Diagnostic Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global COVID-19 Diagnostic Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global COVID-19 Diagnostic Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cellex Basic Information And Sales Area

Table 31: Cellex. Products Portfolio

Table 32: Abbott Basic Information And Sales Area

Table 33: Abbott. Products Portfolio

Table 34: Roche Basic Information And Sales Area

Table 35: Roche. Products Portfolio

Table 36: BioMedomics Basic Information And Sales Area

Table 37: BioMedomics. Products Portfolio

Table 38: BD Basic Information And Sales Area

Table 39: BD. Products Portfolio

Table 40: Henry Schein Basic Information And Sales Area

Table 41: Henry Schein. Products Portfolio

Table 42: Safecare Bio-Tech Basic Information And Sales Area

Table 43: Safecare Bio-Tech. Products Portfolio

Table 44: Mayo Clinic Laboratories Basic Information And Sales Area

Table 45: Mayo Clinic Laboratories. Products Portfolio

Table 46: Chembio Diagnostics Basic Information And Sales Area

Table 47: Chembio Diagnostics. Products Portfolio

Table 48: Mount Sinai Laboratory Basic Information And Sales Area

Table 49: Mount Sinai Laboratory. Products Portfolio

Table 50: Ortho Clinical Diagnostics Basic Information And Sales Area

Table 51: Ortho Clinical Diagnostics. Products Portfolio

Table 52: Zhejiang Orient Gene Biotech Basic Information And Sales Area

Table 53: Zhejiang Orient Gene Biotech. Products Portfolio

Table 54: Innovita Biological Technology Basic Information And Sales Area

Table 55: Innovita Biological Technology. Products Portfolio

Table 56: Guangzhou Wondfo Biotech Basic Information And Sales Area

Table 57: Guangzhou Wondfo Biotech. Products Portfolio

Table 58: Guangdong Hecin-Scientific Basic Information And Sales Area

Table 59: Guangdong Hecin-Scientific. Products Portfolio

Table 60: Dynamiker Biotechnology (Tianjin) Basic Information And Sales Area

Table 61: Dynamiker Biotechnology (Tianjin). Products Portfolio

Table 62: ADVAITE Basic Information And Sales Area

Table 63: ADVAITE. Products Portfolio

Table 64: Segal Basic Information And Sales Area

Table 65: Segal. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global COVID-19 Diagnostic Testing Market Value (USD Million) By Region

Table 71: Global COVID-19 Diagnostic Testing Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

COVID-19 Diagnostic Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cellex; Abbott; Roche; BioMedomics; BD; Henry Schein; Safecare Bio-Tech; Mayo Clinic Laboratories; Chembio Diagnostics; Mount Sinai Laboratory; Ortho Clinical Diagnostics; Zhejiang Orient Gene Biotech; Innovita Biological Technology; Guangzhou Wondfo Biotech; Guangdong Hecin-Scientific; Dynamiker Biotechnology (Tianjin); ADVAITE; Segal
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options